These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1061 related articles for article (PubMed ID: 27436364)

  • 1. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases.
    Mao Q; Wang Y; Bian L; Xu M; Liang Z
    Emerg Microbes Infect; 2016 Jul; 5(7):e75. PubMed ID: 27436364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is a multivalent hand, foot, and mouth disease vaccine feasible?
    Klein M; Chong P
    Hum Vaccin Immunother; 2015; 11(11):2688-704. PubMed ID: 26009802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China.
    Jiang H; Zhang Z; Rao Q; Wang X; Wang M; Du T; Tang J; Long S; Zhang J; Luo J; Pan Y; Chen J; Ma J; Liu X; Fan M; Zhang T; Sun Q
    Emerg Microbes Infect; 2021 Dec; 10(1):619-628. PubMed ID: 33682641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.
    Liu CC; Guo MS; Wu SR; Lin HY; Yang YT; Liu WC; Chow YH; Shieh DB; Wang JR; Chong P
    Antiviral Res; 2016 May; 129():58-66. PubMed ID: 26899790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease.
    Fang CY; Liu CC
    Expert Rev Vaccines; 2018 Sep; 17(9):819-831. PubMed ID: 30095317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological and etiological characteristics of herpangina and hand foot mouth diseases in Jiangsu, China, 2013-2014.
    Yao X; Bian LL; Lu WW; Li JX; Mao QY; Wang YP; Gao F; Wu X; Ye Q; Li XL; Zhu FC; Liang Z
    Hum Vaccin Immunother; 2017 Apr; 13(4):823-830. PubMed ID: 27768527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enterovirus spectrum from the active surveillance of hand foot and mouth disease patients under the clinical trial of inactivated Enterovirus A71 vaccine in Jiangsu, China, 2012-2013.
    Yao X; Bian LL; Lu WW; Li JX; Mao QY; Wang YP; Gao F; Wu X; Ye Q; Xu M; Li XL; Zhu FC; Liang ZL
    J Med Virol; 2015 Dec; 87(12):2009-17. PubMed ID: 26010334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological surveillance of hand, foot and mouth disease in Shanghai in 2014-2016, prior to the introduction of the enterovirus 71 vaccine.
    Li J; Pan H; Wang X; Zhu Q; Ge Y; Cai J; Li Y; Xia A; Hu J; Zeng M
    Emerg Microbes Infect; 2018 Mar; 7(1):37. PubMed ID: 29559626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology and clinical features of hand, foot and mouth disease requiring hospitalization after the use of enterovirus A71 inactivated vaccine in chengdu, China, 2017-2022: a descriptive study.
    Duan X; Zhang C; Wang X; Ren X; Peng H; Tang X; Zhang L; Chen Z; Ye Y; Zheng M; Zhong W; Chen X; Zeng Y; Yuan P; Long L
    Emerg Microbes Infect; 2022 Dec; 11(1):2510-2519. PubMed ID: 36103331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination.
    Takahashi S; Liao Q; Van Boeckel TP; Xing W; Sun J; Hsiao VY; Metcalf CJ; Chang Z; Liu F; Zhang J; Wu JT; Cowling BJ; Leung GM; Farrar JJ; van Doorn HR; Grenfell BT; Yu H
    PLoS Med; 2016 Feb; 13(2):e1001958. PubMed ID: 26882540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hand-Foot-and-Mouth Disease, Aseptic Meningitis, and Encephalitis Caused by Enterovirus].
    Fujimoto T
    Brain Nerve; 2018 Feb; 70(2):121-131. PubMed ID: 29433113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hand, foot, and mouth disease associated with coxsackievirus A10: more serious than it seems.
    Bian L; Gao F; Mao Q; Sun S; Wu X; Liu S; Yang X; Liang Z
    Expert Rev Anti Infect Ther; 2019 Apr; 17(4):233-242. PubMed ID: 30793637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spatial-temporal distribution and etiological characteristics of hand-foot-and-mouth disease before and after EV‑A71 vaccination in Kunming, China, 2017-2020.
    Wang M; Chen T; Peng J; Luo Y; Du L; Lu Z; He J; Liu C; Gan Q; Ma W; Cun Z; Zheng Q; Chen W; Chen Y; Han M; Liu G; Li J
    Sci Rep; 2022 Oct; 12(1):17028. PubMed ID: 36220850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of genetic changes, pathogenicity and antigenicity on Enterovirus- A71 vaccine development.
    Yee PTI; Laa Poh C
    Virology; 2017 Jun; 506():121-129. PubMed ID: 28384566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy.
    Aswathyraj S; Arunkumar G; Alidjinou EK; Hober D
    Med Microbiol Immunol; 2016 Oct; 205(5):397-407. PubMed ID: 27406374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and managements of severe hand, foot and mouth disease caused by enterovirus A71 and coxsackievirus A16 in Shanghai, China.
    Cai K; Wang Y; Guo Z; Yu H; Li H; Zhang L; Xu S; Zhang Q
    BMC Infect Dis; 2019 Mar; 19(1):285. PubMed ID: 30917800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of single-step multiplex real-time RT-PCR assays for rapid diagnosis of enterovirus 71, coxsackievirus A6, and A16 in patients with hand, foot, and mouth disease.
    Puenpa J; Suwannakarn K; Chansaenroj J; Vongpunsawad S; Poovorawan Y
    J Virol Methods; 2017 Oct; 248():92-99. PubMed ID: 28662914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological survey of neutralizing antibodies to eight major enteroviruses among healthy population.
    Zhu R; Cheng T; Yin Z; Liu D; Xu L; Li Y; Wang W; Liu J; Que Y; Ye X; Tang Q; Zhao Q; Ge S; He S; Xia N
    Emerg Microbes Infect; 2018 Jan; 7(1):2. PubMed ID: 29323107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a multivalent enterovirus subunit vaccine based on immunoinformatic design principles for the prevention of HFMD.
    Deng H; Yu S; Guo Y; Gu L; Wang G; Ren Z; Li Y; Li K; Li R
    Vaccine; 2020 Apr; 38(20):3671-3681. PubMed ID: 32247566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Antigenic Peptide-Based Vaccine and Neutralizing Antibodies against Viruses Causing Hand, Foot, and Mouth Disease.
    Anasir MI; Poh CL
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.